[Long-term follow-up of HBeAg-positive patients after interferon-alpha treatment for chronic hepatitis B].
Goeser
T
T
Medizinische Universitätsklinik Heidelberg, Abt. für Gastroenterologie, Infektionen und Vergiftungen.
D003348:Cortisone / Q000008:administration & dosage; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005500:Follow-Up Studies; D006509:Hepatitis B / Q000175:diagnosis / Q000628:therapy*; D006513:Hepatitis B e Antigens / Q000097:blood*; D006521:Hepatitis, Chronic / Q000175:diagnosis / Q000628:therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage*; D008111:Liver Function Tests; D011446:Prospective Studies; D011994:Recombinant Proteins
D006513:Hepatitis B e Antigens; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D003348:Cortisone